Related Experiment Video
Updated: Jun 12, 2026

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and
D Nowinski1, A Koskela, E Kiwanuka
1Department of Surgical Sciences, Plastic Surgery Unit, Uppsala University, Uppsala, Sweden. daniel.nowinski@akademiska.se
Abstract:
Connective tissue growth factor (CTGF/CCN2) is a matricellular protein induced by transforming growth factor (TGF)-beta and intimately involved with tissue repair and overexpressed in various fibrotic conditions. We previously showed that keratinocytes in vitro downregulate TGF-beta-induced expression of CTGF in fibroblasts by an interleukin (IL)-1 alpha-dependent mechanism. Here, we investigated further the mechanisms of this downregulation by both IL-1alpha and beta. Human dermal fibroblasts and NIH 3T3 cells were treated with IL-1alpha or beta in presence or absence of TGF-beta1. IL-1 suppressed basal and TGF-beta-induced CTGF mRNA and protein expression. IL-1alpha and beta inhibited TGF-beta-stimulated CTGF promoter activity, and the activity of a synthetic minimal promoter containing Smad 3-binding CAGA elements. Furthermore, IL-1alpha and beta inhibited TGF-beta-stimulated Smad 3 phosphorylation, possibly linked to an observed increase in Smad 7 mRNA expression. In addition, RNA interference suggested that TGF-beta activated kinase1 (TAK1) is necessary for IL-1 inhibition of TGF-beta-stimulated CTGF expression. These results add to the understanding of how the expression of CTGF in human dermal fibroblasts is regulated, which in turn may have implications for the pathogenesis of fibrotic conditions involving the skin.
Insights
Interleukin-1 (IL-1) alpha and beta suppress connective tissue growth factor (CTGF) production, revealing a new mechanism for regulating fibrotic processes in skin.
Area of Science:
- Cell Biology
- Biochemistry
- Dermatology
Background:
- Connective tissue growth factor (CTGF/CCN2) is a key protein in tissue repair and is overexpressed in fibrotic conditions.
- Transforming growth factor-beta (TGF-beta) induces CTGF expression.
- Keratinocytes can downregulate TGF-beta-induced CTGF in fibroblasts via Interleukin-1 alpha (IL-1 alpha).
Purpose of the Study:
- To investigate the mechanisms by which IL-1 alpha and IL-1 beta downregulate CTGF expression.
- To explore the role of Smad signaling and TGF-beta activated kinase 1 (TAK1) in IL-1 mediated CTGF suppression.
Main Methods:
- Human dermal fibroblasts and NIH 3T3 cells were treated with IL-1 alpha or IL-1 beta in the presence or absence of TGF-beta1.
- CTGF mRNA and protein expression levels were measured.
- CTGF promoter activity and Smad 3-binding CAGA element activity were assessed.
- Smad 3 phosphorylation and Smad 7 mRNA expression were analyzed.
- RNA interference was used to investigate the role of TAK1.
Main Results:
- IL-1 alpha and IL-1 beta suppressed both basal and TGF-beta-induced CTGF mRNA and protein expression.
- IL-1 inhibited TGF-beta-stimulated CTGF promoter activity and Smad 3-binding CAGA element activity.
- IL-1 treatment led to decreased Smad 3 phosphorylation and increased Smad 7 mRNA expression.
- TAK1 was identified as necessary for IL-1's inhibition of TGF-beta-stimulated CTGF expression.
Conclusions:
- IL-1 alpha and IL-1 beta effectively suppress CTGF expression in fibroblasts through mechanisms involving Smad signaling and TAK1.
- These findings enhance the understanding of CTGF regulation in dermal fibroblasts.
- The results may have implications for understanding and treating fibrotic skin conditions.
Related Concept Videos
TGF - β Signaling Pathway
Introduction to Fibroblasts
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply

